- €62.36m
- €71.72m
- $23.54m
C2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 45.1 | 45.1 | 28.1 | 25.5 | 23.5 |
Cost of Revenue | |||||
Gross Profit | 4.35 | 14.6 | 8.84 | 12.2 | 6.4 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 89.4 | 55.6 | 31.7 | 25.9 | 34.6 |
Operating Profit | -44.3 | -10.5 | -3.64 | -0.447 | -11 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -44.7 | -12 | -6.54 | -4.8 | -11.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | -47.2 | -12.1 | -6.48 | -4.87 | -11.5 |
Net Income Before Extraordinary Items | |||||
Net Income | -47.2 | -12.1 | -6.48 | -4.87 | -11.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -47.2 | -12.1 | -6.48 | -4.87 | -11.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.19 | -0.022 | -0.067 | -0.051 | -0.086 |